Last reviewed · How we verify
NCT07423364
Evaluation of A Reproductive Health Education Program in Women Living With HIV
NA trial testing a reproductive health education program in HIV (Human Immunodeficiency Virus) in 60 participants. Completed in 1 June 2022.
1 July 2021
Quick facts
| Lead sponsor | Okan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 1 July 2020 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- a reproductive health education program
Conditions studied
- HIV (Human Immunodeficiency Virus) — all drugs for HIV (Human Immunodeficiency Virus) →
Sponsor
Okan University
Who can join
Adults 18 to 49, female only, with HIV (Human Immunodeficiency Virus). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to evaluate the effectiveness of a reproductive health education program designed and implemented using Pender's Health Promotion Model for women living with HIV.The study was designed as a prospective controlled experimental study. The hypotheses tested in the study include the following questions: * Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV increase the reproductive health knowledge level of HIV-positive women? * Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence healthy lifestyle behaviors related to women's health among HIV-positive women? * Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence lifestyle behaviors related to general health among HIV-positive women?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07423364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV (Human Immunodeficiency Virus)
Currently open trials in the same condition.
- NCT07495059 — Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care · NA · recruiting
- NCT07115901 — Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release · NA · recruiting
- NCT07336797 — Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy · Phase 2 · recruiting
- NCT07062614 — Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a · recruiting
- NCT07150871 — Impact of Covid-19 on Syphilis · active not recruiting
Other Okan University trials
Trials by the same sponsor.
- NCT07457034 — Digital Follow-Up and Nursing Education in Bariatric Surgery Patients · NA · not yet recruiting
- NCT07457905 — THE RELATIONSHIP BETWEEN PAIN ANXIETY AND POST-OPERATIVE PAIN IN PATIENTS UNDERGOING CHOLECYSTECTOMY SURGERY · not yet recruiting
- NCT07462832 — Effect of Connective Tissue Massage in Low Back Pain · NA · not yet recruiting
- NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07423364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Okan University
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07423364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing